Lilly voluntary admission: working dinner with overseas psychiatry associations breached hospitality and high standards rules (AUTH/1908/11/06)

📅 2006 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/1908/11/06
CompanyEli Lilly and Company Limited
TypeVoluntary admission treated as a complaint (potentially inappropriate hospitality)
IssueArrangements for a meeting / hospitality and attendee eligibility
Meeting purpose (as described)Introduce new neuroscience manager; facilitate handover; discuss potential partnership/support with four overseas psychiatry associations; discuss changes in environment and the Code
Associations involvedSri Lankan Psychiatry Association (SLPA); British Indian Psychiatry Association (BIPA); British Pakistani Psychiatry Association (BPPA); British Arab Psychiatry Association (BAPA)
Date proceedings commenced3 November 2006
Case completed20 December 2006
Applicable Code year2006
Breach clauses9.1; 19.1
No breachClause 2
Attendees (HCPs)10 health professionals (9 consultant psychiatrists; 1 ward sister); Panel noted two attendees were spouses and not qualifying delegates
Costs£947.95 reported (room £250; dinner £420; drinks £277.95). Panel noted £947.50 total; adjusted per-head cost £68.61 including room hire (after removing two meals not taken).
VenuePrivate room (Marriott Hotel referenced in context)
SanctionsUndertaking received
AppealNo appeal
PublishedFebruary 2007 Code of Practice Review

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • Lilly voluntarily advised the PMCPA it had breached the Code regarding a meeting for health professionals (a working dinner in a private room) on Friday 8 September 2006.
  • The meeting was arranged to introduce Lilly’s new neuroscience manager and facilitate a handover, and to discuss potential partnership/support with four associations forming “A Great Partnership” (SLPA, BIPA, BPPA, BAPA).
  • There was no formal agenda; no materials were provided before or during the dinner.
  • Invitations were issued verbally by the President of one association at Lilly’s request; it was unclear whether Lilly specified who should be invited or whether the purpose was explained to potential attendees beforehand.
  • Attendees: 10 health professionals (9 consultant psychiatrists and 1 ward sister) plus 3 Lilly employees were referenced in the report; the Panel focused on the 10 health professional attendees and noted that two were spouses of officers and not officers themselves.
  • Costs reported: £947.95 (room hire £250; dinner for 15 @ £28 = £420; drinks £277.95). The Panel noted total cost £947.50 for 13 attendees, including £56 for two meals not taken; adjusted cost per head for those who attended was £68.61 including room hire.
  • Lilly initially described the dinner as “in part, a promotional meeting for Zyprexa (olanzapine)” and not approved in the usual way; later corrected this, stating no Lilly products were discussed.
  • Lilly stated the meeting was not approved in line with its SOPs; it disciplined the organiser and investigated the other two employees present.
⚖️

Outcome

  • Breach of Clause 19.1 (hospitality): two spouses, although health professionals, did not qualify as delegates in their own right; therefore the meeting did not comply with Clause 19.1 requirements.
  • Breach of Clause 9.1 (high standards): high standards had not been maintained.
  • No breach of Clause 2: the Panel considered the meeting had a legitimate purpose and did not bring discredit upon the pharmaceutical industry.
  • Sanction recorded: undertaking received.
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training